Leiv Lea

Insider Reports History

Entity
Individual
Location
Pharmacyclics Inc, 995 E Arques Ave, Sunnyvale, CA
Signature
/s/ Leiv Lea
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Leiv Lea:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Corvus Pharmaceuticals, Inc. Chief Financial Officer Common Stock 149K $366K $2.45 Dec 13, 2022 By Trust
Corvus Pharmaceuticals, Inc. Chief Financial Officer Common Stock 133K $326K $2.45 Dec 14, 2022 By IRA
Corvus Pharmaceuticals, Inc. Chief Financial Officer Stock Option (Right to Buy) 200K Dec 6, 2023 Direct

Insider Reports Filed by Leiv Lea

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRVS Corvus Pharmaceuticals, Inc. Dec 6, 2023 1 $0 4 Dec 8, 2023 Chief Financial Officer
CRVS Corvus Pharmaceuticals, Inc. Dec 13, 2022 2 $25.6K 4 Dec 15, 2022 Chief Financial Officer
CRVS Corvus Pharmaceuticals, Inc. Aug 11, 2022 1 $0 4 Aug 15, 2022 Chief Financial Officer
CRVS Corvus Pharmaceuticals, Inc. Mar 16, 2022 2 $77K 4 Mar 17, 2022 Chief Financial Officer
CRVS Corvus Pharmaceuticals, Inc. Sep 9, 2021 1 $0 4 Sep 13, 2021 Chief Financial Officer